Vertex Pharmaceuticals (VRTX)

Add to Watchlists
Create an Alert
97.01 +0.80  +0.83% NASDAQ Jul 29, 16:59 Delayed 2m USD

Vertex Pharmaceuticals Cash from Financing (TTM):

143.21M for March 31, 2016
View 4,000+ financial data types
Browse...
View Full Chart

Vertex Pharmaceuticals Cash from Financing (TTM) Chart

Export Data
Save Image

Vertex Pharmaceuticals Historical Cash from Financing (TTM) Data

View and export this data going back to 1990. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2016 143.21M
Dec. 31, 2015 188.92M
Sept. 30, 2015 199.31M
June 30, 2015 521.92M
March 31, 2015 549.24M
Dec. 31, 2014 549.24M
Sept. 30, 2014 525.11M
June 30, 2014 180.88M
March 31, 2014 304.96M
Dec. 31, 2013 248.41M
Sept. 30, 2013 169.20M
June 30, 2013 164.34M
March 31, 2013 144.54M
Dec. 31, 2012 172.20M
Sept. 30, 2012 -15.61M
June 30, 2012 -3.694M
March 31, 2012 -86.36M
Dec. 31, 2011 -124.24M
Sept. 30, 2011 68.19M
June 30, 2011 446.62M
March 31, 2011 401.06M
Dec. 31, 2010 425.06M
Sept. 30, 2010 954.27M
June 30, 2010 686.37M
March 31, 2010 687.98M
   
Dec. 31, 2009 999.01M
Sept. 30, 2009 474.06M
June 30, 2009 568.43M
March 31, 2009 547.43M
Dec. 31, 2008 620.74M
Sept. 30, 2008 617.75M
June 30, 2008 360.39M
March 31, 2008 378.44M
Dec. 31, 2007 -10.19M
Sept. 30, 2007 -6.615M
June 30, 2007 345.64M
March 31, 2007 347.05M
Dec. 31, 2006 365.86M
Sept. 30, 2006 367.20M
June 30, 2006 59.12M
March 31, 2006 219.04M
Dec. 31, 2005 197.46M
Sept. 30, 2005 185.29M
June 30, 2005 172.43M
March 31, 2005 -7.993M
Dec. 31, 2004 -8.626M
Sept. 30, 2004 4.576M
June 30, 2004 14.64M
March 31, 2004 26.40M
Dec. 31, 2003 37.47M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Advertisement

VRTX Cash from Financing (TTM) Benchmarks

Companies
Regeneron Pharmaceuticals -543.74M
Celgene 4.173B
Biomarin Pharmaceutical -24.04M

VRTX Cash from Financing (TTM) Range, Past 5 Years

Minimum -124.24M Dec 2011
Maximum 549.24M Dec 2014
Average 205.25M

VRTX Cash from Financing (TTM) Excel Add-In Codes

  • Metric Code: cash_financing_ttm
  • Latest data point: =YCP("VRTX", "cash_financing_ttm")
  • Last 5 data points: =YCS("VRTX", "cash_financing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.